Chairman Wu Xiukun was invited to attend the Macao International Trade and Investment Fair.
Release time:
2021-12-23
This exhibition set upthe "China Traditional Chinese Medicine Health (Macao) Brand Exhibition" and other themed exhibition areas such as the "Science and Technology Innovation Exhibition Area.
2021Year12Month10Day,"The 26th Macao International Trade and Investment Fair"was held in Macao, and Chairman Wu Xiukun was invited as a representative of"the National Foreign Trade Transformation and Upgrading Base (Biomedicine) in Jinwan, Zhuhai, Guangdong Province."to attend the exhibition.
This exhibition set upthe "China Traditional Chinese Medicine Health (Macao) Brand Exhibition" and other themed exhibition areas such as the "Science and Technology Innovation Exhibition Area." Zhuhai Miditech actively integrates into the national development strategy, participating in the Guangdong-Macao Deep Cooperation Zone, the Guangdong-Hong Kong-Macao Greater Bay Area, the China-Portuguese-speaking Countries Cooperation Platform, and the "Belt and Road" Initiative.
The company has had close and in-depth discussions with Macao research institutions and pharmaceutical companies multiple times, reaching several cooperation agreements, developing multiple projects in collaboration with Macao research institutions, and registering several traditional Chinese medicine varieties in cooperation with Macao pharmaceutical companies for production in Macao. Currently, the implementation is progressing as planned, and the traditional Chinese medicine varieties are expected to go international throughthe "Belt and Road".
Zhuhai Miditech Biopharmaceutical Co., Ltd., a national high-tech enterprise, is located in the Biomedicine Industrial Park in Jinwan District, Zhuhai City, Guangdong Province. The company focuses on traditional Chinese medicine.The core product is Sanjie Pian (for treating liver cancer, liver cirrhosis, and preventing the recurrence and metastasis of liver cancer), and it also has a number of excellent exclusive patents and anti-tumor traditional Chinese medicines used in TCM clinics for many years, such as Baishan Pian (for treating lung cancer and nasopharyngeal cancer, has obtained clinical approval), Rukangning Capsules (for treating breast cancer), Gongning Capsules (for treating cervical cancer), and Xiaojieling Capsules (for treating gastric cancer and intestinal cancer),committed to building the largest traditional Chinese medicine anti-tumor base in the country.
Related Information
Traditional Chinese Medicine for Liver Cancer and Liver Cirrhosis - Sanjie Pian, safeguarding 447 million chronic liver disease patients.
2022Year4Month15to21The day is the28first National Cancer Prevention and Control Publicity Week
In 2021, the anti-liver cancer traditional Chinese medicine - Sanjie Pian passed the expert review by the Ministry of Science and Technology, achieving a level of technological advancement that is considered leading in the country. The research and development results have been included in the National Science and Technology Achievements Database (No. 6012021Y0389). It was publicly announced on the National Science and Technology Achievements Registration Work Platform (Guokewang) in March 2022.